Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study

Trials. 2020 Mar 30;21(1):296. doi: 10.1186/s13063-020-04245-x.

Yuqin Chen¹, Wenjun He¹, Haiping Ouyang¹, Chunli Liu¹, Cheng Hong¹, Tao Wang¹, Kai Yang¹, Wenju Lu¹, Jian Wang^{2

3}

¹ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou, Guangdong, 510120, People's Republic of China.
² State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou, Guangdong, 510120, People's Republic of China. jianwang1@email.arizona.edu.
³ Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona College of Medicine, Tucson, AZ, USA. jianwang1@email.arizona.edu.

Abstract

After publication of our article [1] the authors have notified us of two typos in the Trial status.